A Comparison of the Effects of Citicoline and Piracetam on Hypoxic-ischemic Brain Damage in Neonatal Rabbits
Iranian Journal of Child Neurology,
Vol. 16 No. 1 (2022),
1 January 2022
,
Page 77-84
https://doi.org/10.22037/ijcn.v15i4.29816
Abstract
Abstract
Objectives
Perinatal hypoxic-ischemic brain injuries have been a major cause of mortality and neurodevelopmental morbidities in newborns. Citicoline and Piracetam have been used as nootropic agents in a number of studies. In this investigation, we aimed to determine the effects of these agents solely and in combination in hypoxicischemic brain damage in rabbit neonates.
Materials & Methods
Hypoxic-ischemic brain damage was induced by the occlusion of both uterine arteries of dams for eight minutes. The subjects were randomly divided into five groups as follows (n=6 per group): control group without hypoxia (C1), control group with hypoxicischemic damage (C2), the third group (P) received Piracetam (100 mg/kg), the fourth group (T) administered with Citicoline (250 mg/ kg), and the fifth (PT) received both. The preventive effects of the two drugs on hypoxic-ischemic brain damage were microscopically investigated by the rates of damage to the hippocampus.
Results
Neuronal destruction rates in C1, C2, P, T, and PT were 4%, 45%, 37.5%, 12.5% (P=0.01 vs. C2), and 20% (P=0.03 vs. C2), respectively. The total means of hypoxic-ischemic damage, cell edema, neuronal degeneration, and eosinophilic degeneration were lower in the T group compared to C2 (P<0.05).
Conclusion
According to our results and previous findings, Citicoline as a treatment for hypoxic-ischemic brain injuries could be beneficial, and it has priority over neuroprotective agents like Piracetam. Moreover, the combination of Citicoline and Piracetam showed no superior effect in contrast with Citicoline alone. However, experimental studies on larger populations and clinical trials are highly suggested
- Citicoline
- Rabbits
- Hypoxia
- Ischemia
- Brain damage
How to Cite
References
Busl KM, Greer DM. Hypoxic-ischemic brain injury: pathophysiology, neuropathology,
and mechanisms. NeuroRehabilitation. 2010;26(1):5-13.
Lu-Emerson C, Khot S. Neurological sequelae of hypoxic-ischemic brain injury. NeuroRehabilitation. 2010;26(1):35-45.
Anderson CA, Arciniegas DB. Cognitive sequelae of hypoxic-ischemic brain injury: a review. NeuroRehabilitation. 2010;26(1):47-63.
Vannucci RC, Connor JR, Mauger DT, Palmer C, Smith MB, Towfighi J, et al. Rat model of perinatal hypoxic-ischemic brain damage. Journal of neuroscience research. 1999;55(2):158-63.
Costello AM, Manandhar DS. Perinatal asphyxia in less developed countries. Arch Dis Child Fetal Neonatal Ed. 1994;71(1):F1-F3.
de L. Costello AM. Perinatal health in developing countries. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1993;87(1):1- 2.
Robertson CM, Finer NN, Grace MG. School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term. The Journal of pediatrics. 1989;114(5):753-60.
Shankaran S, Woldt E, Koepke T, Bedard MP, Nandyal R. Acute neonatal morbidity and long-term central nervous system sequelae of perinatal asphyxia in term infants. Early human development. 1991;25(2):135-48.
Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Wholebody
hypothermia for neonates with hypoxic– ischemic encephalopathy. New England Journal of Medicine. 2005;353(15):1574-84.
Secades JJ, Lorenzo JL. Citicoline- Pharmacological and Clinical Review, 2006 Update. Methods and findings in experimental and clinical pharmacology. 2006;28(Supplement B):1-56.
Adibhatla RM, Hatcher J, Dempsey R. Citicoline: neuroprotective mechanisms in cerebral ischemia. Journal of neurochemistry. 2002;80(1):12-23.
Conant R, Schauss AG. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature. Alternative medicine review. 2004;9(1):17-31.13. Overgaard K. The effects of citicoline on acute ischemic stroke: a review. Journal of Stroke and Cerebrovascular Diseases. 2014;23(7):1764-9.
Secades JJ. Probably role of citicoline in stroke rehabilitation: review of the literature. Rev Neurol. 2012;54(3):173-9.
Winblad B. Piracetam: A Review of Pharmacological Properties and Clinical Uses. CNS Drug Reviews. 2005;11(2):169-82.
Noble S, Benfield P. Piracetam: a review of its potential as a rehabilitative treatment after stroke. CNS Drugs. 1996;5:1-12.
Doijad R, Pathan A, Pawar N, Baraskar S, Maske V, Gaikwad S. Therapeutic applications of citicoline and piracetam as fixed dose combination. Journal of Pharma and Bio Science. 2012;2(12):15-20.
Biagas K. Hypoxic-ischemic brain injury: advancements in the understanding of mechanisms and potential avenues for therapy. Curr Opin Pediatr. 1999;11(3):223-8.
Palmer C, Vannucci RC, Towfighi J. Reduction of perinatal hypoxic-ischemic brain damage with allopurinol. Pediatric research. 1990;27(4 Pt 1):332-6.
Bennet L, Tan S, Van den Heuij L, Derrick M, Groenendaal F, van Bel F, et al. Cell therapy for
neonatal hypoxia–ischemia and cerebral palsy. Annals of Neurology. 2012;71(5):589-600.
Chen H, Zhou M, Liang C, Huang D, Guojie Y, Lin Z, et al. The effects of early adminisration
of Astragalus on brain injury in neonates with severe asphyxia. Clinical Medicine of China.
;25(6):593-5.
Başkaya MK, Doğan A, Rao AM, Dempsey RJ. Neuroprotective effects of citicoline on brain edema and blood—brain barrier breakdown after traumatic brain injury. Journal of neurosurgery 2000;92(3):448-52.
Fiedorowicz M, Makarewicz D, Stańczak- Mrozek KI, Grieb P. CDP-choline (citicoline) attenuates brain damage in a rat model of birth asphyxia. Acta Neurobiol Exp. 2008;68(3):389-97.
Warach S, Creed Pettigrew L, Dashe JF, Pullicino P, Lefkowitz DM, Sabounjian L, et al. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Annals of Neurology. 2000;48(5):713-22.
Nasiri J, Kargar M. Combination of citicoline and physiotherapy in children with cerebral palsy. International journal of preventive medicine. 2014;5(10):1308.
WANG D-m, LI G-h, JIA C-m. Clinical Observation of Citicoline in The Treatment of Hypoxic Ischemic Encephalopathy in Newborns [J]. Nei Moivgol Medical Journal. 2005;3.
Wheble PC, Sena ES, Macleod MR. A systematic review and meta-analysis of the efficacy of piracetam and piracetam-like compounds in experimental stroke. Cerebrovascular diseases (Basel, Switzerland). 2008;25(1-2):5 11.
He Z, Liao Y, Zheng M, Zeng F-D, Guo L-J. Piracetam Improves Cognitive Deficits Caused by Chronic Cerebral Hypoperfusion in Rats. Cellular and Molecular Neurobiology. 2008;28(4):613-27.
Kessler J, Thiel A, Karbe H, Heiss WD. Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. Stroke. 2000;31(9):2112-6.
Ennaceur A, Delacour J. Effect of combined or separate administration of piracetam and choline on learning and memory in the rat. Psychopharmacology. 1987;92(1):58-67.
- Abstract Viewed: 1115 times